'Analytical development' presentation slideshows

Microbial Services Approach to QbD and Process Characterization Case Study

705 views • 39 slides

Amorphous State

Amorphous State. An amorphous polymer does not exhibit a crystalline X-ray diffraction pattern, and it does not have a first-order melting transition. Solid or Liquid?. Is there any Chain Order in Amorphous State?. Short Range Interactions In axial direction of a chain Kuhn segment length

709 views • 30 slides

Development of UK EBO Analysis The Big Picture

Development of UK EBO Analysis The Big Picture. Philip Jones Team Leader (Operational Effects Analysis) Dstl Policy and Capability Studies Dstl/CP16578. Why. What. Policy statements.

349 views • 25 slides

Improved SSA through Orbit Determination of Two-Line Element Sets

Improved SSA through Orbit Determination of Two-Line Element Sets. David A. Vallado, Benjamin Bastida Virgili , and Tim Flohrer. Paper 6ECSD 13-4a.0-7 presented at the 6 th European Conference on Space Debris in Darmstadt, Germany, 2013 April 22-25. Outline. Introduction

319 views • 20 slides

Terminal Sterilization Process At Vxp Biologics

VxP Biologics provides the comprehensive Research & Development and Current Good Manufacturing Products services for the production of biological product. VxP Biologics partner with clients to seamlessly integrate process design, process qualification, and continued process verification data. Visit: http://vxpbiologics.com/services/manufacturing/process-optimization/

317 views • 19 slides

Umbrella Criteria Workshop Update

Umbrella Criteria Workshop Update. March 15-16, 2011. Jeni Keisman (UMCES at EPA CBP). The Umbrella Criteria Workshop Steering Committee. Walter Boynton (UMCES-CBL) Claire Buchanan (ICPRB) Marjy Friedrichs (VIMS, STAC representative) Matthew Hall (MD DNR) Rick Hoffman (VADEQ)

286 views • 15 slides

Terminal Sterilization Process Optimization At VxP Biologics

A critical milestone to ensuring successful biologics production campaign is having a stable and repeatable process. Terminal sterilization is routinely applied to a wide variety of implantable medical devices and other medical products that are used during implantation procedures. All parenterals, ophthalmic products and medical devices are subjected to terminal sterilization. Products are sterilized terminally in batches as they are manufactured. Contact: VxP Biologics Services Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Phone: 3177592299 For More Info Visit: http://vxpbiologics.com/services/manufacturing/process-optimization/

188 views • 11 slides

Pharma Contract Manufacturing

Nitto Avecia Pharma Services has earned its notoriety for giving extraordinary systematic testing from little atoms to biologics for almost 30 years. With the expansion of a best in class producing office staffed by a portion of the business' most experienced plan researchers, Avecia Pharma manages its customers and speeds up their opportunity to advertise.

26 views • 2 slides

CDMO manufacturing

Learn more about our CDMO and our reputation for providing outstanding analytical testing from small molecules to biologics for nearly 30 years!

28 views • 2 slides

Analytical Method Development and Validation

Producing biosimilars is quite challenging as drug manufacturers face multiple bottlenecks while ensuring product quality and patient safety. Analytical method development and validation provides the data needed to manufacture safe and valuable drugs.

126 views • 2 slides